Praxis Precision Medicines (PRAX) Other Non Operating Income (2020 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Other Non Operating Income of $13.3 million for Q1 2026, up 144.83% year-over-year from $5.4 million in Q1 2025, and up 63.52% quarter-over-quarter from $8.1 million in Q4 2025.
Praxis Precision Medicines (PRAX) Other Non Operating Income (2020 - 2026) Analysis & Trends
Praxis Precision Medicines' Other Non Operating Income history runs 7 years deep, the most recent figure standing at $13.3 million for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 144.83% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $30.8 million (up 50.63% YoY), while the FY2025 annual figure was $22.9 million, up 32.19% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $13.3 million, up from $8.1 million in the prior quarter.
- The five-year high for Other Non Operating Income was $13.3 million in Q1 2026, with the low at $132000.0 in Q1 2022.
- The 5-year median for Other Non Operating Income is $2.3 million (2024), against an average of $3.4 million.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income jumped 642.44% in 2024, then dropped 10.15% in 2025.
- Praxis Precision Medicines' Other Non Operating Income stood at $280000.0 in 2022, then surged by 231.43% to $928000.0 in 2023, then jumped by 468.64% to $5.3 million in 2024, then jumped by 54.12% to $8.1 million in 2025, then soared by 63.52% to $13.3 million in 2026.
- Business Quant data shows PRAX's Other Non Operating Income at $13.3 million in Q1 2026, $8.1 million in Q4 2025, and $4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.18 Mn |
| Mar 31, 2026 | 13.30 Mn |
| Dec 31, 2025 | 8.13 Mn |
| Sep 30, 2025 | 4.43 Mn |
| Jun 30, 2025 | 4.94 Mn |
| Mar 31, 2025 | 5.43 Mn |
| Dec 31, 2024 | 5.28 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Jun 30, 2024 | 4.81 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 928,000.00 |
| Sep 30, 2023 | 884,000.00 |
| Jun 30, 2023 | 648,000.00 |
| Mar 31, 2023 | 636,000.00 |
| Dec 31, 2022 | 280,000.00 |
| Sep 30, 2022 | 345,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 132,000.00 |
| Sep 30, 2021 | 73,000.00 |
| Jun 30, 2021 | 82,000.00 |